|
The nutraceutical industry is now undergoing increased scientific scrutiny and validation to position itself to complement with pharmaceuticals, providing a more holistic and evidence-based approach to healthcare.
In fact, nutraceutical industry is rapidly transforming into a cornerstone of precision-driven healthcare. Now, dietary supplements and wellness products which come under the category of nutraceuticals are replacing pharmaceuticals with long-term, side-effect-free alternatives. For example, polyphenols like resveratrol are showing promising results in cardiovascular health, while adaptogens like Ashwagandha are now being clinically studied for stress modulation and cortisol regulation, said Amit Srivastava, founder and chief catalyst, Nutrify Today.
The $500 billion global nutraceutical industry is becoming the frontline of preventive medicine, and this shift is only accelerating. The regulatory climate is also catching up, with agencies such as the FSSAI, EFSA, and the US FDA introducing stricter guidelines. Nutraceuticals is now proving its efficacy at the cellular level, backed by clinical data and peer-reviewed science, he added.
“We see technology as the real game-changer. Emerging platforms are utilising machine learning to analyse massive, audited datasets across biochemistry, pharmacology, and global regulatory frameworks, enabling the design of nutraceutical products that are not only effective but also market-ready from the outset,” said Srivastava.
AI tools are increasingly evaluating mechanisms at the cellular level, ensuring compliance in multiple global markets, and integrating blockchain to validate every ingredient source. This helps to introduce products faster to market, with traceability, safety, and efficacy embedded in the development process, he noted.
There is also a shift from mass formulations to hyper-personalized nutraceuticals. Advances in nutrigenomics and microbiome sequencing, can now design interventions that align with an individual's DNA profile, gut health, and even real-time biomarkers. A diabetic patient in Mumbai and one in Minnesota may have the same clinical condition, but entirely different nutritional needs. Traditional medicine groups them under the same treatment plan. Disruptive nutraceutical science treats them as individuals. This move toward personalised, precision nutrition is already showing results, said Srivastava.
But inconsistent regulations fragment the global nutraceutical market. What is permitted in one country may be banned in another, and what is allowed in one market may face delays elsewhere. However, AI-powered tools are now integrating compliance checks at the product blueprinting stage itself. Some platforms even generate regulatory dossiers automatically, allowing companies to launch with confidence in multiple geographies, he said.
Forward-looking platforms aid access to vetted, audited supply chain partners. Every ingredient, from ashwagandha root to omega-3 algae oil, now comes with traceability, sustainability checks, and blockchain-validated history. This levels the playing field for startups while raising the bar for incumbents. Supply chain transparency is a necessity as adulteration and mislabelling are real threats. The future of nutraceutical lies in ecosystems that bring together regulators, scientists, business leaders, and investors to co-create the future of responsible nutrition, said Srivastava.
|